McKesson

Connection together puzzle pieces Concept of business strategy collaboration
Favicon Fierce Pharma

McKesson acquires Maryland CRO for $2.25 billion

Healthcare conglomerate McKesson has dropped $2.25 billion for Precision Medicine Group's R&D and commercialization capabilities.
Donavyn Coffey Aug 25, 2026 11:22am
McKesson

McKesson swaps stake in surgical unit to Apollo Funds for $1.25B

Apr 22, 2026 7:57am